Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Ostrer

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2013
Gene flow from North Africa contributes to differential human genetic diversity in southern EuropeLaura R Botigué, Brenna M Henn, Simon Gravel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2012
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancerSarah L Kerns, Richard Stock, Nelson Stone, et al.
Plos Biology|September 16, 2009
Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determinationDebora Bogani, Pam Siggers, Rachel Brixey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetesSarah L Kerns, Jaime Guevara-Aguirre, Shayne Andrew, et al.
European Journal of Human Genetics : EJHG|August 12, 2010
Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variantMaurice P Zeegers, Humera S Khan, Leo J Schouten, et al.
Seminars in Radiation Oncology|September 19, 2015
The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward PreventionSarah L Kerns, Suman Kundu, Jung Hun Oh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 4, 2015
Expanded genetic screening panel for the Ashkenazi Jewish populationBrett Baskovich, Susan Hiraki, Kinnari Upadhyay, et al.
Cancer Research|April 19, 2005
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer riskVirginia G Kaklamani, Lisa Baddi, Junjian Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2013
STROGAR - STrengthening the Reporting Of Genetic Association studies in RadiogenomicsSarah L Kerns, Dirk de Ruysscher, Christian N Andreassen, et al.
The New England Journal of Medicine|April 25, 2003
A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndromeTamar Ben-Yosef, Seth L Ness, Anne C Madeo, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2013
Gene flow from North Africa contributes to differential human genetic diversity in southern EuropeLaura R Botigué, Brenna M Henn, Simon Gravel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2012
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancerSarah L Kerns, Richard Stock, Nelson Stone, et al.
Plos Biology|September 16, 2009
Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determinationDebora Bogani, Pam Siggers, Rachel Brixey, et al.
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetesSarah L Kerns, Jaime Guevara-Aguirre, Shayne Andrew, et al.
European Journal of Human Genetics : EJHG|August 12, 2010
Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variantMaurice P Zeegers, Humera S Khan, Leo J Schouten, et al.
Seminars in Radiation Oncology|September 19, 2015
The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward PreventionSarah L Kerns, Suman Kundu, Jung Hun Oh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 4, 2015
Expanded genetic screening panel for the Ashkenazi Jewish populationBrett Baskovich, Susan Hiraki, Kinnari Upadhyay, et al.
Cancer Research|April 19, 2005
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer riskVirginia G Kaklamani, Lisa Baddi, Junjian Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2013
STROGAR - STrengthening the Reporting Of Genetic Association studies in RadiogenomicsSarah L Kerns, Dirk de Ruysscher, Christian N Andreassen, et al.
The New England Journal of Medicine|April 25, 2003
A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndromeTamar Ben-Yosef, Seth L Ness, Anne C Madeo, et al.
Pageof 12